Anti-Myelin Protein Zero 抗体 [EPR20383] (ab183868)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR20383] to Myelin Protein Zero
- Suitable for: IP, WB, IHC-P, IHC-Fr, ICC/IF
- Reacts with: Mouse, Rat, Human
Related conjugates and formulations
製品の概要
-
製品名
Anti-Myelin Protein Zero antibody [EPR20383]
Myelin Protein Zero 一次抗体 製品一覧 -
製品の詳細
Rabbit monoclonal [EPR20383] to Myelin Protein Zero -
由来種
Rabbit -
アプリケーション
適用あり: IP, WB, IHC-P, IHC-Fr, ICC/IFmore details -
種交差性
交差種: Mouse, Rat, Human -
免疫原
Recombinant full length protein. This information is proprietary to Abcam and/or its suppliers.
-
ポジティブ・コントロール
- WB: Human, mouse and rat sciatic nerve lysates. IHC-P: Human peripheral nerves; Mouse and rat sciatic nerves. IHC-Fr: Mouse and rat sciatic nerves.
-
特記事項
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
バッファー
pH: 7.2
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA -
Concentration information loading...
-
精製度
Protein A purified -
ポリ/モノ
モノクローナル -
クローン名
EPR20383 -
アイソタイプ
IgG -
研究分野
関連製品
-
Alternative Versions
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
-
Related Products
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab183868の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
IP |
1/20.
|
|
WB |
1/1000. Detects a band of approximately 26-28 kDa (predicted molecular weight: 28 kDa).
|
|
IHC-P | (1) |
1/500. Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
|
IHC-Fr |
1/50.
|
|
ICC/IF |
1/100.
|
特記事項 |
---|
IP
1/20. |
WB
1/1000. Detects a band of approximately 26-28 kDa (predicted molecular weight: 28 kDa). |
IHC-P
1/500. Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
IHC-Fr
1/50. |
ICC/IF
1/100. |
ターゲット情報
-
機能
Creation of an extracellular membrane face which guides the wrapping process and ultimately compacts adjacent lamellae. -
組織特異性
Found only in peripheral nervous system Schwann cells. -
関連疾患
Defects in MPZ are the cause of Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200]. CMT1B is a form of Charcot-Marie-Tooth disease, the most common inherited disorder of the peripheral nervous system. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathy or CMT1, and primary peripheral axonal neuropathy or CMT2. Neuropathies of the CMT1 group are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet.
Defects in MPZ are the cause of Charcot-Marie-Tooth disease type 2I (CMT2I) [MIM:607677]. CMT2I is a form of Charcot-Marie-Tooth disease, the most common inherited disorder of the peripheral nervous system. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathy or CMT1, and primary peripheral axonal neuropathy or CMT2. Neuropathies of the CMT2 group are characterized by signs of axonal regeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. CMT2I is characterized by late onset (range 47 to 60 years).
Defects in MPZ are the cause of Charcot-Marie-Tooth disease type 2J (CMT2J) [MIM:607736]. CMT2J is a form of Charcot-Marie-Tooth disease characterized by the association of axonal peripheral neuropathy with hearing loss and pupillary abnormalities such as Adie pupil. Inheritance is autosomal dominant.
Defects in MPZ are the cause of Adie pupil (ADIEP) [MIM:103100]. A stationary, benign disorder characterized by tonic, sluggishly reacting pupil and hypoactive or absent tendon reflexes. Adie pupil is a characteristic of Charcot-Marie-Tooth disease type 2J.
Defects in MPZ may be the cause of Charcot-Marie-Tooth disease dominant intermediate type D (CMTDID) [MIM:607791]. CMTDID is a form of Charcot-Marie-Tooth disease characterized by features intermediate between demyelinating and axonal peripheral neuropathies, and motor median nerve conduction velocities ranging from 25 to 45 m/sec.
Defects in MPZ are a cause of Dejerine-Sottas syndrome (DSS) [MIM:145900]; also known as Dejerine-Sottas neuropathy (DSN) or hereditary motor and sensory neuropathy III (HMSN3). DSS is a severe degenerating neuropathy of the demyelinating Charcot-Marie-Tooth disease category, with onset by age 2 years. DSS is characterized by motor and sensory neuropathy with very slow nerve conduction velocities, increased cerebrospinal fluid protein concentrations, hypertrophic nerve changes, delayed age of walking as well as areflexia. There are both autosomal dominant and autosomal recessive forms of Dejerine-Sottas syndrome.
Defects in MPZ are a cause of congenital hypomyelination neuropathy (CHN) [MIM:605253]. CHN is characterized clinically by early onset of hypotonia, areflexia, distal muscle weakness, and very slow nerve conduction velocities.
Defects in MPZ are a cause of Roussy-Levy syndrome (ROULS) [MIM:180800]; also known as Roussy-Levy hereditary areflexic dystasia. This autosomal dominant disorder resembles Charcot-Marie-Tooth disease type 1 in that it presents with foot deformity, weakness and atrophy of distal limb muscles, especially the peronei, and absent tendon reflexes. The phenotype differs, however, in that it includes static tremor of the upper limbs and gait ataxia. -
配列類似性
Belongs to the myelin P0 protein family.
Contains 1 Ig-like V-type (immunoglobulin-like) domain. -
翻訳後修飾
N-glycosylated; contains sulfate-substituted glycan. -
細胞内局在
Membrane. - Information by UniProt
-
参照データベース
- Entrez Gene: 4359 Human
- Entrez Gene: 17528 Mouse
- Entrez Gene: 24564 Rat
- Omim: 159440 Human
- SwissProt: P25189 Human
- SwissProt: P27573 Mouse
- SwissProt: P06907 Rat
- Unigene: 591486 Human
see all -
別名
- Charcot Marie Tooth neuropathy 1B antibody
- CHM antibody
- CMT1 antibody
see all
画像
-
All lanes : Anti-Myelin Protein Zero antibody [EPR20383] (ab183868) at 1/5000 dilution
Lane 1 : Mouse sciatic nerve lysate
Lane 2 : Mouse liver lysate
Lane 3 : Mouse brain lysate
Lane 4 : Rat sciatic nerve lysate
Lane 5 : Rat liver lysate
Lane 6 : Rat brain lysate
Lysates/proteins at 4 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Predicted band size: 28 kDa
Observed band size: 26-28 kDa why is the actual band size different from the predicted?
Exposure time: 1 secondBlocking/Dilution buffer: 5% NFDM/TBST.
The MW observed is consistent with the literature (PMID 10704451; PMID 1384988).
Negative control: liver, brain tissue (PMID 2578885, PMID 25288117).
-
Immunohistochemical analysis of paraffin-embedded human peripheral nerves labeling Myelin Protein Zero with ab183868 at 1/500 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Membranous staining on Schwann cells of human peripheral nerves (PMID: 21057508).
Counter stained with Hematoxylin.
Secondary antibody only control: Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
-
Immunocytochemistry/ Immunofluorescence analysis of S42 (rat sciatic nerve epithelial-like cell) labeling Myelin Protein Zero with ab183868 at 1/100 dilution, followed by ab150081 at 1/1000 dilution. ab195889 at 1/200 was used as the counterstain antibody. Nuclear counterstain was DAPI (blue). Cells were fixed wiht 4% Paraformaldehyde and permeabilised with 0.1% TritonX-100.
Confocal image showing membranous and cytoplasmic staining in S42 cell line. Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8). -
Immunocytochemistry/ Immunofluorescence analysis of S16 (rat Sciatic nerve epithelial-like) labeling Myelin Protein Zero with ab183868 at 1/100 dilution, followed by ab150081 at 1/1000 dilution. ab195889 at 1/200 was used as the counterstain antibody. Nuclear counterstain was DAPI (blue). Cells were fixed wiht 4% Paraformaldehyde and permeabilised with 0.1% TritonX-100.
Confocal image showing membranous and cytoplasmic staining in S16 cell line. Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8). -
Immunohistochemical analysis of 4% paraformaldehyde-fixed, 0.2% Triton X-100 permeabilized frozen mouse sciatic nerves labeling Myelin Protein Zero with ab183868 at 1/50 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).
Membranous staining on Schwann cells of mouse sciatic nerves (PMID: 21057508).
The nuclear counterstain is DAPI (blue).
Secondary antibody only control: Used PBS instead of primary antibody, secondary antibody is Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) at 1/1000 dilution.
-
Myelin Protein Zero was immunoprecipitated from Human Sciatic Nerve lysate with ab183868 at 1/20 dilution. Western blot was performed from the immunoprecipitate using ab183868 at 1/5000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10,000 dilution.
Lane 1: Human Sciatic Nerve lysate 10ug (Input).
Lane 2: ab183868 IP in Human Sciatic Nerve lysate.
Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab183868 in Human Sciatic Nerve lysate.
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 3 minutes.
-
Immunohistochemical analysis of paraffin-embedded mouse sciatic nerves labeling Myelin Protein Zero with ab183868 at 1/500 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Membranous staining on Schwann cells of mouse sciatic nerves (PMID: 21057508).
Counter stained with Hematoxylin.
Secondary antibody only control: Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
-
All lanes : Anti-Myelin Protein Zero antibody [EPR20383] (ab183868) at 1/1000 dilution
Lane 1 : Human sciatic nerve lysate
Lane 2 : Human fetal liver lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Predicted band size: 28 kDa
Observed band size: 26-28 kDa why is the actual band size different from the predicted?
Exposure time: 30 secondsBlocking/Dilution buffer: 5% NFDM/TBST.
The MW observed is consistent with the literature (PMID 10704451; PMID 1384988).
Negative control: liver tissue (PMID 2578885).
-
Immunohistochemical analysis of 4% paraformaldehyde-fixed, 0.2% Triton X-100 permeabilized frozen rat sciatic nerves labeling Myelin Protein Zero with ab183868 at 1/50 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).
Membranous staining on Schwann cells of rat sciatic nerves (PMID: 21057508).
The nuclear counterstain is DAPI (blue).
Secondary antibody only control: Used PBS instead of primary antibody, secondary antibody is Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) at 1/1000 dilution.
-
Immunohistochemical analysis of paraffin-embedded rat sciatic nerves labeling Myelin Protein Zero with ab183868 at 1/500 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Membranous staining on Schwann cells of rat sciatic nerves (PMID: 21057508).
Counter stained with Hematoxylin.
Secondary antibody only control: Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
プロトコール
データシートおよび資料
-
SDS download
-
Datasheet download
Certificate of Compliance
参考文献 (6)
ab183868 は 6 報の論文で使用されています。
- Pestronk A et al. Schwann cells and myelin in human peripheral nerve: Major protein components vary with age, axon size and pathology. Neuropathol Appl Neurobiol 49:e12898 (2023). PubMed: 36868780
- Sadri M et al. Tumor necrosis factor receptor-1 is selectively sequestered into Schwann cell extracellular vesicles where it functions as a TNFα decoy. Glia 70:256-272 (2022). PubMed: 34559433
- Di Z et al. Single-cell and WGCNA uncover a prognostic model and potential oncogenes in colorectal cancer. Biol Proced Online 24:13 (2022). PubMed: 36117173
- Bonnet M et al. Immediate or Delayed Transplantation of a Vein Conduit Filled with Nasal Olfactory Stem Cells Improves Locomotion and Axogenesis in Rats after a Peroneal Nerve Loss of Substance. Int J Mol Sci 21:N/A (2020). PubMed: 32290426
- Elsayed H et al. Development and Characterisation of an in vitro Model of Wallerian Degeneration. Front Bioeng Biotechnol 8:784 (2020). PubMed: 32754584
- Brifault C et al. Deletion of the Gene Encoding the NMDA Receptor GluN1 Subunit in Schwann Cells Causes Ultrastructural Changes in Remak Bundles and Hypersensitivity in Pain Processing. J Neurosci 40:9121-9136 (2020). PubMed: 33051351